Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations
NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) — Life Sciences Investor Forum today announced that the presentations from the June 24th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.
This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.
REGISTER OR LOGIN AT: https://bit.ly/3j2S9Si
June 24th Presenting Companies:
| Presenting Company | Ticker(s) |
| Cybin Inc. | (OTCQB: CLXPF | NEO: CYBN) |
| Else Nutrition Holdings Inc | (OTCQX: BABYF | TSX-V: BABY) |
| Shield Therapeutics PLC | (OTCQX: SHIEF | LSE: STX) |
| Innocan Pharma Corp. | (OTCQB: INNPF | CSE: INNO) |
| Lexaria Bioscience Corp. | (NASDAQ: LEXX, | CSE: LXX) |
| Diffusion Pharmaceuticals Inc. | (NASDAQ: DFFN) |
| Field Trip Health Ltd. | (OTCQX: FTRPF | TSX: FTRP) |
| InMed Pharmaceuticals Inc. | (NASDAQ: INM) |
| Assure Holdings Corp | (OTCQB: ARHH | TSX-V: IOM) |
| VolitionRx Limited | (NYSE AMERICAN: VNRX) |
| Avricore Health Inc. | (OTCQB: AVCRF | TSX-V: AVCR) |
| Starpharma Holdings Ltd. | (OTCQX: SPHRY | ASX: SPL) |
| NeonMind Biosciences Inc. | (OTCQB: NMDBF | CSE: NEON) |
To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.
About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
CONTACT: CONTACT Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 johnv@lifesciencesinvestorforum.com
Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…
Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…
LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…
Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…
A Revolutionary ATCA/VME/VXI 3D-Flow Board: 512 Channels, >2,800 Programmable Operations—Scalable to >50,000 Operations on Each…
After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…